Asarina Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 38495712
Rigensgade 11 A, 1316 København K
peter.nordkild@asarinapharma.com
tel: 25471646
www.asarinapharma.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -1 890.78 | - 887.27 | - 508.85 | - 884.34 | - 365.45 |
| Gross profit | -1 890.78 | - 887.27 | - 508.85 | - 884.34 | - 365.45 |
| Employee benefit expenses | -5 268.17 | -3 309.95 | -1 925.87 | -2 461.12 | - 457.22 |
| Other operating expenses | -45 047.29 | -21 058.21 | -4 173.88 | -3 698.02 | - 400.39 |
| Total depreciation | -4 036.19 | -4 257.12 | -4 257.12 | -37 063.79 | - 284.23 |
| EBIT | -56 242.43 | -29 512.55 | -10 865.73 | -44 107.27 | -1 507.30 |
| Other financial income | 247.87 | 169.07 | 63.25 | 80.53 | 6.17 |
| Other financial expenses | -1 033.68 | - 228.81 | -94.62 | -52.19 | -33.74 |
| Pre-tax profit | -57 028.25 | -29 572.29 | -10 897.10 | -44 078.92 | -1 534.87 |
| Income taxes | 5 500.00 | 4 867.58 | 1 074.28 | 1 175.73 | 201.64 |
| Net earnings | -51 528.25 | -24 704.72 | -9 822.82 | -42 903.19 | -1 333.23 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 44 725.34 | 40 752.45 | 36 779.56 | ||
| Intangible assets total | 44 725.34 | 40 752.45 | 36 779.56 | ||
| Machinery and equipment | 1 357.86 | 1 073.63 | 789.40 | 505.16 | 220.93 |
| Tangible assets total | 1 357.86 | 1 073.63 | 789.40 | 505.16 | 220.93 |
| Investments total | 22.63 | 22.63 | 18.58 | 13.61 | |
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 80.76 | 108.87 | 58.21 | 73.15 | 27.82 |
| Current deferred tax assets | 5 500.00 | 4 867.58 | 1 046.50 | 1 175.73 | 201.64 |
| Short term receivables total | 5 580.76 | 4 976.44 | 1 104.71 | 1 248.88 | 229.46 |
| Cash and bank deposits | 9 920.56 | 3 854.29 | 4 957.24 | 722.76 | 1 150.74 |
| Cash and cash equivalents | 9 920.56 | 3 854.29 | 4 957.24 | 722.76 | 1 150.74 |
| Balance sheet total (assets) | 61 607.14 | 50 679.44 | 43 649.48 | 2 490.41 | 1 601.14 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 95 555.50 | 73 646.12 | 52 481.75 | 44 079.08 | 1 175.89 |
| Profit of the financial year | -51 528.25 | -24 704.72 | -9 822.82 | -42 903.19 | -1 333.23 |
| Shareholders equity total | 44 077.25 | 48 991.41 | 42 708.93 | 1 225.89 | - 107.34 |
| Non-current owed to group member | 8 316.19 | ||||
| Non-current liabilities total | 8 316.19 | ||||
| Current loans from credit institutions | 12.15 | 2.83 | |||
| Current trade creditors | 8 105.97 | 1 220.24 | 320.44 | 140.81 | 146.83 |
| Current owed to group member | 906.27 | ||||
| Other non-interest bearing current liabilities | 1 107.73 | 467.79 | 607.96 | 1 120.89 | 655.38 |
| Current liabilities total | 9 213.70 | 1 688.03 | 940.55 | 1 264.53 | 1 708.48 |
| Balance sheet total (liabilities) | 61 607.14 | 50 679.44 | 43 649.48 | 2 490.41 | 1 601.14 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.